top of page

The Equity Priority

At GENEQ Global, equity in genomics and precision healthcare is not just a 'nice to have' - it is something we work towards every day.

Whether that is innovating new technology; ensuring that our genomic tests are accessible; publishing our findings on genomic equity assurance; or providing our clients with GENEQ Global's 'Genomic Equity Data Assessment', we live and breathe 'the equity priority'.

Genomic Equity Data Assessment (GEDA) 

GENEQ Global offers systematic evaluation of genomic datasets, screening programmes, and research initiatives to identify representation gaps, population biases, and equity barriers in genomic medicine implementation.

We provide population representation audits, 
quantitative analysis of ancestry, geographic, and socioeconomic representation across our clients' genomic data assets using:

  • Benchmarking against global disease burden distributions and identify underserved populations.

  • Bias detection & reporting

  • Algorithmic and statistical assessment of variant databases, polygenic risk scores, and clinical decision tools for population-specific performance disparities.

  • Gap Analysis

  • Mapping of research coverage against WHO priority conditions and regional health needs

  • Identification of diseases and populations systematically excluded from current genomic evidence.

  • Equity Metrics Dashboard

  • Custom reporting framework with actionable KPIs tracking diversity, inclusion, and equitable access across our clients' genomic programmes.

GEDA
Engagement & Outputs

Typical Engagements for GENEQ Global include:
 

  • National screening programme equity reviews

  • Biobank diversity assessments

  • Clinical genomics service audits

  • Research portfolio gap analysis

  • Regulatory submission support (equity documentation)


Our Outputs include:
 

  • Executive summary with priority findings

  • Technical report with methodology and data sources

  • Actionable recommendations ranked by impact and feasibility

  • Monitoring framework for ongoing equity tracking

bottom of page